Profile

AgPlus Diagnostics

AgPlus Diagnostics has developed a diagnostic platform technology based on research conducted at the UK’s National Physical Laboratory (NPL).

AgPlus’ platform technology combines novel electrochemistry and metallic nanoparticles signalling with diagnostic immunoassays to provide high sensitivity and fully quantitative analyte detection. The AgPlus ADVANTAGE handheld portable reader and single-use test cartridge are expected to be used across multiple applications and sectors, critically where fast cost-effective diagnostic results will enable users to make decisions, with confidence, in minutes, not hours or days.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology

Website www.agplusdiagnostics.com/

Associated Team Members

Relevant News

Rainbow Seed Fund Invests in AgPlus Diagnostics

28 September 2016 AgPlus’ handheld electrochemical reader to deliver the next generation of rapid diagnostics…

read more

AgPlus at AACC

Fiona Marshall, CEO of AgPlus will be attending AACC, if anyone would like to...

read more

AgPlus welcomes new board members

AgPlus is please to announce the appointment of two new board members: Mr Rupert...

read more

Privacy Policy

AgPlus is committed to respecting your privacy and protecting your personal information. We will be...

read more

More Companies in Medical / Biotechnology

Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now

×